Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has expanded approval of TALZENNA® (talazoparib) in combination with XTANDI® (enzalutamide) to the treatment of ...
Johnson & Johnson (NYSE:JNJ) today announced new results from Cohort 5 of the Phase 1b/2 OrigAMI-4 study showing deep and durable responses with first-line subcutaneous amivantamab and ...
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...
Leading life scientist Wu Jun, who recently left the United States to return to his homeland, believes many of the world’s ...
Global DNA Methylation Market size is expected to be worth around US$ 6.5 Billion by 2034 from US$ 1.6 Billion in 2024.
Acute myeloid leukemia (AML) is marked by unchecked expansion of undifferentiated myeloid cells. Although oncogenic fusions ...
See all of Florence Rosier’s articles in Le Monde, Number 1 website for news. Newspaper articles and all the news, all the time: International, France, Society, Economy, Culture, Environment, etc.
The phase 2 EVITA trial (NCT03682029) was the first double-blind, randomized, placebo-controlled study of oral vitamin C in patients with preleukemic conditions or lower-risk myeloid malignancies. 1 ...
Get the latest articles and news from Understanding Animal Research in your email inbox every month. For more information, ...
Using genome editing to trace cell lineages, researchers capture the early history of the mouse embryo in unprecedented detail ...
A new study from EMBL Rome shows how embryos precisely coordinate gene activity during early development. The research is published in the journal Science Advances. Shortly after fertilization, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results